Weicheng Pharmaceuticals

Suzhou, China · Founded 2025 · Privately Held (backing)

Developer of a proprietary extrahepatic drug delivery platform designed to advance targeted small nucleic acid therapies beyond hepatic tissues. Weicheng Pharmaceuticals is based in Suzhou, China and was founded in 2025. It has raised $64 million.

Last price · $/share
—
Implied valuation
—
Total raised
$64.0M
Last round
—

Who backs Weicheng Pharmaceuticals?

4 investors
InvestorType
Qiming Venture PartnersVenture capital
Highlight CapitalOther
Apricot Capital (Shanghai)—
TF Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Weicheng Pharmaceuticals investors

4 investors are on record for Weicheng Pharmaceuticals, including Qiming Venture Partners, Highlight Capital, Apricot Capital (Shanghai) and TF Capital.

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Weicheng Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View